Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) studying neurobehavior are seeking patients with cortical basal ganglionic degeneration for cognitive neuroscience studies.
Eligible patients should be mild to moderately affected, between the ages of 18 and 70, and have no other current significant disease. Those enrolled in the study will undergo neuropsychological testing and brain imaging studies. The studies will be conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. All study-related expenses will be paid by the NIH.
For more information, physicians should contact Dr. Jordan Grafman, Chief, Cognitive Neuroscience Section, NINDS, Building 10, Room 5C205, 10 Center Drive MSC 1440; Bethesda, MD 20892-1440; telephone: (301) 496-0220; fax: (301) 480-2909; email: grafmanj@ninds.nih.gov.
This content has been adapted from the original NINDS Notes publication. For the most up-to-date funding information, please visit the Funding Opportunities section of the NINDS web site. For the most recent information on NINDS studies, please visit the NINDS Patient Recruitment web site.